Bayer opens $250m cell therapy plant to advance regenerative medicines
The facility aims to help break an industry-wide bottleneck in manufacturing capacity for regenerative medicine and create readiness for the first production runs of potential commercial launches. Bayer AG announced today the opening of a cell and gene therapy manufacturing plant which aims to create the capacity to bring cell therapies to patients on a […]